Gene · 8744
Papers3,166
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,166
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The role of IL‑17, IFN‑γ, 4‑1BBL and tumour‑infiltrating lymphocytes in the occurrence, development and prognosis of pancreatic cancer. | Oncol Lett | 2025 | 39677412 | PubTator, text mining | PubMed |
| Oncolytic virus encoding 4-1BBL and IL15 enhances the efficacy of tumor-infiltrating lymphocyte adoptive therapy in HCC. | Cancer Gene Ther | 2025 | 39567771 | PubTator, text mining | PubMed |
| CD34+ and CD34- MM cells show different immune-checkpoint molecule expression profiles: high expression of CD112 and CD137 ligand on CD34+ MM cells. | Int J Hematol | 2025 | 39531203 | PubTator, text mining | PubMed |
| Generation and characterization of OX40-ligand fusion protein that agonizes OX40 on T-Lymphocytes. | Front Immunol | 2024 | 39867912 | PubTator, text mining | PubMed |
| Intratumoral delivery of lipid nanoparticle-formulated mRNA encoding IL-21, IL-7, and 4-1BBL induces systemic anti-tumor immunity. | Nat Commun | 2024 | 39639025 | PubTator, text mining | PubMed |
| Single-cell sequencing reveals cellular heterogeneity of nucleus pulposus in intervertebral disc degeneration. | Sci Rep | 2024 | 39516278 | PubTator, text mining | PubMed |
| Metabolic programs drive function of therapeutic NK cells in hypoxic tumor environments. | Sci Adv | 2024 | 39475618 | PubTator, text mining | PubMed |
| Tumor necrosis factor superfamily signaling: life and death in cancer. | Cancer Metastasis Rev | 2024 | 39363128 | PubTator, text mining | PubMed |
| Characteristics of PD-1+CD4+ T cells in peripheral blood and synovium of rheumatoid arthritis patients. | Clin Transl Immunology | 2024 | 39345753 | PubTator, text mining | PubMed |
| Tannic acid elicits differential gene regulation in prostate cancer apoptosis. | Acta Pharm | 2024 | 39279521 | PubTator, text mining | PubMed |
| Theoretical basis, state and challenges of living cell-based drug delivery systems. | Theranostics | 2024 | 39267776 | PubTator, text mining | PubMed |
| The effect of rs2910686 on ERAP2 expression in IBD and epithelial inflammatory response. | J Transl Med | 2024 | 39123229 | PubTator, text mining | PubMed |
| Bibliometric analysis reveals the research hotspots and trends of nasopharyngeal carcinoma immunotherapy. | Hum Vaccin Immunother | 2024 | 39034441 | PubTator, text mining | PubMed |
| Hypoxia conduces the glioma progression by inducing M2 macrophage polarization via elevating TNFSF9 level in a histone-lactylation-dependent manner. | Am J Physiol Cell Physiol | 2024 | 39010835 | PubTator, text mining | PubMed |
| TNFSF9 Is Associated with Favorable Tumor Immune Microenvironment in Patients with Renal Cell Carcinoma Who Are Treated with the Combination Therapy of Nivolumab and Ipilimumab. | Int J Mol Sci | 2024 | 39000552 | PubTator, text mining | PubMed |
| An Extended Flow Cytometry Evaluation of ex Vivo Expanded NK Cells Using K562.Clone1, a Feeder Cell Line Manufactured in Brazil. | Transplant Cell Ther | 2024 | 38986739 | PubTator, text mining | PubMed |
| Integrated Bioinformatics Analysis Revealed Immune Checkpoint Genes Relevant to Type 2 Diabetes. | Diabetes Metab Syndr Obes | 2024 | 38881696 | PubTator, text mining | PubMed |
| Soluble Plasma Proteins of Tumor Necrosis Factor and Immunoglobulin Superfamilies Reveal New Insights into Immune Regulation in People with HIV and Opioid Use Disorder. | Vaccines (Basel) | 2024 | 38793771 | PubTator, text mining | PubMed |
| Advancements in clinical RNA therapeutics: Present developments and prospective outlooks. | Cell Rep Med | 2024 | 38744276 | PubTator, text mining | PubMed |
| PM21-particle stimulation augmented with cytokines enhances NK cell expansion and confers memory-like characteristics with enhanced survival. | Front Immunol | 2024 | 38711506 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8744/papers?page=8